A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Here, some of the greatest films of all time based on true stories. This Best Picture-winning film also brought Colin Firth the Best Actor Oscar for his complex portrayal of King George VI.

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ... granted following FDA priority review, ...

You should change the pads every 48 hours, and note that they do not work on moles, birthmarks, warts with hair growing from them, genital warts, or facial warts. The brand notes that you should not ...

The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with treatment ...

Budget Highlights: Gareeb, youth, annadata and naari feature in Budget. What about taxes? New vs Old tax regime: Here's a decoder to help you choose the right one Will you pay more under new tax ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living ... granted following FDA priority review, was based on the results of a randomized ...